Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 1996

View Archived Issues

Novel thrombin inhibitors in development at LG Chemical

Heterocyclic tachykinin antagonists revealed by Zeneca

New NK1 antagonists from Ciba-Geigy

Protein tyrosine kinase inhibitors from Warner-Lambert

Anti-TGF-beta MAbs from Celtrix

BMS describes thrombin-activatable plasminogen activator

Japanese researchers describe analgesic tripeptides

Dolastatin 10 derivatives from Teikoku Hormone

Natural antitumor/antifungal agent disclosed by Fujisawa

End-of-the-year European launches for protease inhibitors

U.K. launch for aromatase inhibitor

Bayer launches sustained-release calcium antagonist in U.K.

German launch for bisphosphonate

Thrombolytic agent introduced in Germany

Pharmagenesis forms Chinese joint venture

FDA identifies issues to be addressed for AccuSite approval

U.S. researchers report link between NO formation and AIDS dementia

Geron/P&U collaboration on telomerase inhibitors

Neoprobe files first marketing application with FDA

FDA clears oral monotherapy for PID

Genome Therapeutics and Schering-Plough genomic-based collaboration

Breath-activated inhaler from IVAX licensed to Glaxo Wellcome

Bayer antibacterial cleared for wider use by FDA

Nutropin cleared for marketing

Combination antihypertensive product cleared by FDA

Expanded use of acellular DTP vaccine approved

FDA clears angiotensin II blocker from Ciba

Hyperprolactinemia Rx approved by FDA

Novel anticonvulsant approved by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...